| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nucleosomes | 75 | 2024 | 489 | 7.110 |
Why?
|
| Chromatin | 80 | 2024 | 2967 | 5.850 |
Why?
|
| Drosophila Proteins | 34 | 2023 | 1713 | 3.440 |
Why?
|
| Histones | 50 | 2023 | 2593 | 3.090 |
Why?
|
| Chromatin Assembly and Disassembly | 20 | 2023 | 632 | 2.990 |
Why?
|
| DNA-Binding Proteins | 77 | 2021 | 9618 | 2.430 |
Why?
|
| Adenosine Triphosphatases | 25 | 2020 | 842 | 2.260 |
Why?
|
| Transcription Factors | 93 | 2021 | 12166 | 2.230 |
Why?
|
| Chromosomal Proteins, Non-Histone | 19 | 2020 | 731 | 2.180 |
Why?
|
| Transcription, Genetic | 56 | 2019 | 7599 | 1.810 |
Why?
|
| Genes, Homeobox | 9 | 2017 | 289 | 1.730 |
Why?
|
| Heat-Shock Proteins | 28 | 2004 | 797 | 1.670 |
Why?
|
| Repressor Proteins | 26 | 2014 | 2986 | 1.660 |
Why?
|
| DNA Helicases | 32 | 2021 | 853 | 1.640 |
Why?
|
| Embryonic Stem Cells | 8 | 2021 | 1249 | 1.430 |
Why?
|
| Gene Expression Regulation, Developmental | 13 | 2021 | 3612 | 1.410 |
Why?
|
| Epigenesis, Genetic | 14 | 2022 | 3826 | 1.410 |
Why?
|
| Transfection | 24 | 2017 | 5758 | 1.350 |
Why?
|
| Gene Expression Regulation | 47 | 2021 | 11914 | 1.350 |
Why?
|
| Nuclear Proteins | 40 | 2015 | 5802 | 1.340 |
Why?
|
| DNA | 41 | 2017 | 7211 | 1.300 |
Why?
|
| Adenosine Triphosphate | 25 | 2013 | 2003 | 1.270 |
Why?
|
| Drosophila melanogaster | 22 | 2019 | 1723 | 1.250 |
Why?
|
| Gene Silencing | 12 | 2017 | 1501 | 1.230 |
Why?
|
| HeLa Cells | 47 | 2021 | 3092 | 1.210 |
Why?
|
| Saccharomyces cerevisiae Proteins | 20 | 2019 | 1839 | 1.140 |
Why?
|
| Cell Differentiation | 20 | 2022 | 11659 | 1.090 |
Why?
|
| Transcriptional Activation | 15 | 2020 | 1748 | 1.080 |
Why?
|
| Embryoid Bodies | 3 | 2021 | 65 | 1.020 |
Why?
|
| RNA-Binding Proteins | 12 | 2021 | 1883 | 0.970 |
Why?
|
| Enhancer Elements, Genetic | 9 | 2021 | 1368 | 0.880 |
Why?
|
| Genes, Reporter | 3 | 2021 | 1524 | 0.860 |
Why?
|
| RNA, Untranslated | 5 | 2019 | 457 | 0.850 |
Why?
|
| Homeodomain Proteins | 10 | 2017 | 2429 | 0.820 |
Why?
|
| Promoter Regions, Genetic | 37 | 2017 | 5800 | 0.780 |
Why?
|
| Protein Processing, Post-Translational | 7 | 2021 | 1967 | 0.760 |
Why?
|
| Protein Binding | 38 | 2021 | 9346 | 0.750 |
Why?
|
| Fungal Proteins | 16 | 2001 | 906 | 0.740 |
Why?
|
| Calcium Phosphates | 4 | 2003 | 172 | 0.740 |
Why?
|
| Consumer Product Safety | 1 | 2021 | 122 | 0.720 |
Why?
|
| Cell Nucleus | 12 | 2023 | 2887 | 0.720 |
Why?
|
| Endogenous Retroviruses | 1 | 2021 | 112 | 0.710 |
Why?
|
| Animals | 141 | 2024 | 169322 | 0.690 |
Why?
|
| Drosophila | 12 | 2021 | 1514 | 0.660 |
Why?
|
| Schizosaccharomyces | 6 | 2019 | 237 | 0.660 |
Why?
|
| S Phase | 2 | 2020 | 423 | 0.640 |
Why?
|
| Cell Line | 27 | 2021 | 15593 | 0.640 |
Why?
|
| Body Patterning | 3 | 2017 | 634 | 0.640 |
Why?
|
| Lentivirus | 1 | 2021 | 519 | 0.630 |
Why?
|
| Plasmids | 19 | 2003 | 2267 | 0.620 |
Why?
|
| Histone Code | 2 | 2018 | 160 | 0.580 |
Why?
|
| Genetic Vectors | 6 | 2021 | 3411 | 0.580 |
Why?
|
| Macromolecular Substances | 20 | 2004 | 1435 | 0.580 |
Why?
|
| Binding Sites | 25 | 2014 | 6018 | 0.580 |
Why?
|
| Chromatin Immunoprecipitation | 11 | 2016 | 855 | 0.560 |
Why?
|
| Models, Genetic | 14 | 2014 | 3442 | 0.550 |
Why?
|
| Insect Proteins | 5 | 2002 | 253 | 0.550 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2021 | 465 | 0.550 |
Why?
|
| HSP70 Heat-Shock Proteins | 9 | 2004 | 395 | 0.550 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2021 | 1078 | 0.540 |
Why?
|
| RNA, Viral | 2 | 2021 | 2866 | 0.520 |
Why?
|
| Green Fluorescent Proteins | 1 | 2021 | 2068 | 0.520 |
Why?
|
| Ribonucleoprotein, U1 Small Nuclear | 8 | 2002 | 36 | 0.520 |
Why?
|
| RNA | 4 | 2020 | 2726 | 0.520 |
Why?
|
| Templates, Genetic | 11 | 2008 | 188 | 0.510 |
Why?
|
| Click Chemistry | 1 | 2016 | 101 | 0.500 |
Why?
|
| Biosensing Techniques | 1 | 2021 | 661 | 0.500 |
Why?
|
| Cell Cycle Proteins | 2 | 2024 | 3457 | 0.480 |
Why?
|
| Regulatory Elements, Transcriptional | 3 | 2013 | 182 | 0.480 |
Why?
|
| Unfolded Protein Response | 1 | 2017 | 239 | 0.480 |
Why?
|
| Saccharomyces cerevisiae | 14 | 2019 | 2678 | 0.480 |
Why?
|
| Point Mutation | 6 | 2019 | 1595 | 0.470 |
Why?
|
| Methylation | 11 | 2021 | 1076 | 0.470 |
Why?
|
| Neural Stem Cells | 3 | 2019 | 891 | 0.450 |
Why?
|
| Molecular Sequence Data | 40 | 2015 | 17626 | 0.430 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 6 | 2001 | 221 | 0.430 |
Why?
|
| Selection, Genetic | 3 | 2009 | 877 | 0.420 |
Why?
|
| Mice | 62 | 2021 | 82004 | 0.420 |
Why?
|
| Cell Cycle | 2 | 2020 | 2934 | 0.410 |
Why?
|
| Gene Library | 2 | 2013 | 1061 | 0.410 |
Why?
|
| Multigene Family | 2 | 2013 | 1082 | 0.410 |
Why?
|
| Base Sequence | 39 | 2016 | 12421 | 0.400 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2011 | 450 | 0.390 |
Why?
|
| Silent Information Regulator Proteins, Saccharomyces cerevisiae | 1 | 2011 | 62 | 0.390 |
Why?
|
| Trans-Activators | 14 | 2002 | 2855 | 0.380 |
Why?
|
| Lysine | 8 | 2021 | 988 | 0.380 |
Why?
|
| Catalytic Domain | 3 | 2008 | 698 | 0.380 |
Why?
|
| Zebrafish Proteins | 2 | 2016 | 1019 | 0.370 |
Why?
|
| Response Elements | 3 | 2017 | 308 | 0.370 |
Why?
|
| RNA Polymerase II | 7 | 2020 | 547 | 0.360 |
Why?
|
| Sequence Analysis, DNA | 5 | 2016 | 4774 | 0.360 |
Why?
|
| Protein Structure, Tertiary | 10 | 2011 | 3779 | 0.360 |
Why?
|
| Nucleoproteins | 3 | 2004 | 110 | 0.360 |
Why?
|
| Nucleic Acid Hybridization | 6 | 2016 | 1305 | 0.350 |
Why?
|
| Micrococcal Nuclease | 3 | 2017 | 36 | 0.350 |
Why?
|
| Proteomics | 4 | 2018 | 3906 | 0.340 |
Why?
|
| Recombinant Fusion Proteins | 15 | 2021 | 3728 | 0.330 |
Why?
|
| Radioisotopes | 2 | 2001 | 517 | 0.330 |
Why?
|
| Models, Biological | 10 | 2021 | 9494 | 0.330 |
Why?
|
| Telomere | 3 | 2012 | 943 | 0.330 |
Why?
|
| Genome | 3 | 2013 | 1747 | 0.330 |
Why?
|
| Ribonucleoproteins | 2 | 2015 | 359 | 0.320 |
Why?
|
| X Chromosome | 3 | 2019 | 819 | 0.320 |
Why?
|
| Genomics | 6 | 2021 | 5916 | 0.320 |
Why?
|
| Transcription Initiation Site | 3 | 2020 | 189 | 0.320 |
Why?
|
| Gene Expression Profiling | 5 | 2021 | 9508 | 0.320 |
Why?
|
| Medical Audit | 2 | 2002 | 454 | 0.310 |
Why?
|
| Histone-Lysine N-Methyltransferase | 4 | 2017 | 697 | 0.310 |
Why?
|
| Humans | 146 | 2024 | 768298 | 0.300 |
Why?
|
| Spermatogenesis | 2 | 2023 | 259 | 0.300 |
Why?
|
| RNA, Messenger | 13 | 2020 | 12801 | 0.300 |
Why?
|
| Deoxyribonuclease I | 6 | 2002 | 225 | 0.300 |
Why?
|
| Molecular Chaperones | 4 | 2008 | 762 | 0.300 |
Why?
|
| Amino Acid Sequence | 24 | 2019 | 13425 | 0.300 |
Why?
|
| Yersinia pestis | 1 | 2007 | 33 | 0.290 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2007 | 130 | 0.280 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 7 | 2023 | 792 | 0.280 |
Why?
|
| DNA Methylation | 3 | 2017 | 4419 | 0.270 |
Why?
|
| Hot Temperature | 10 | 2004 | 1440 | 0.270 |
Why?
|
| Thymus Gland | 16 | 2010 | 1266 | 0.270 |
Why?
|
| Cells, Cultured | 23 | 2017 | 19019 | 0.270 |
Why?
|
| Indicators and Reagents | 6 | 2002 | 455 | 0.270 |
Why?
|
| Nucleic Acid Conformation | 6 | 2009 | 900 | 0.270 |
Why?
|
| Chromosome Mapping | 4 | 2017 | 4622 | 0.260 |
Why?
|
| Eukaryotic Cells | 7 | 2003 | 192 | 0.260 |
Why?
|
| Mutant Proteins | 4 | 2012 | 489 | 0.260 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2008 | 308 | 0.250 |
Why?
|
| TATA Box | 3 | 1994 | 127 | 0.250 |
Why?
|
| Models, Molecular | 7 | 2012 | 5408 | 0.250 |
Why?
|
| Documentation | 2 | 2021 | 917 | 0.250 |
Why?
|
| Histone Deacetylases | 6 | 2005 | 717 | 0.250 |
Why?
|
| Molecular Biology | 1 | 2009 | 573 | 0.250 |
Why?
|
| DNA, Recombinant | 3 | 2003 | 455 | 0.250 |
Why?
|
| Gene Expression Regulation, Fungal | 3 | 2019 | 495 | 0.250 |
Why?
|
| DNA Footprinting | 3 | 2008 | 97 | 0.250 |
Why?
|
| Conserved Sequence | 5 | 2019 | 1163 | 0.240 |
Why?
|
| Mesenchymal Stem Cells | 2 | 2013 | 1666 | 0.240 |
Why?
|
| Protein Conformation | 11 | 2009 | 3957 | 0.240 |
Why?
|
| Zebrafish | 2 | 2016 | 3037 | 0.240 |
Why?
|
| Proto-Oncogene Proteins c-myc | 4 | 1995 | 997 | 0.240 |
Why?
|
| CHO Cells | 3 | 2003 | 1380 | 0.230 |
Why?
|
| Silencer Elements, Transcriptional | 1 | 2004 | 10 | 0.230 |
Why?
|
| Acetylation | 8 | 2020 | 1053 | 0.230 |
Why?
|
| Mammals | 6 | 2009 | 1135 | 0.230 |
Why?
|
| Cell Lineage | 3 | 2021 | 2574 | 0.230 |
Why?
|
| Kinetics | 12 | 2008 | 6334 | 0.230 |
Why?
|
| Recombinant Proteins | 11 | 2019 | 6512 | 0.230 |
Why?
|
| Crystallography, X-Ray | 5 | 2012 | 1956 | 0.220 |
Why?
|
| Dosage Compensation, Genetic | 2 | 2017 | 209 | 0.220 |
Why?
|
| Developmental Disabilities | 1 | 2012 | 1516 | 0.220 |
Why?
|
| Heterochromatin | 3 | 2017 | 294 | 0.210 |
Why?
|
| Neurons | 5 | 2021 | 9512 | 0.210 |
Why?
|
| alpha-Fetoproteins | 1 | 2003 | 227 | 0.210 |
Why?
|
| Testis | 1 | 2006 | 783 | 0.210 |
Why?
|
| Mutation | 21 | 2023 | 30230 | 0.210 |
Why?
|
| Hydrolysis | 6 | 2001 | 648 | 0.210 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 1998 | 1246 | 0.210 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2014 | 1889 | 0.200 |
Why?
|
| Neoplasm Proteins | 5 | 2021 | 3609 | 0.200 |
Why?
|
| Acetyltransferases | 3 | 2002 | 231 | 0.200 |
Why?
|
| Embryonic Development | 1 | 2007 | 722 | 0.200 |
Why?
|
| Gene Knockdown Techniques | 2 | 2021 | 1608 | 0.200 |
Why?
|
| Gene Amplification | 3 | 2003 | 1090 | 0.200 |
Why?
|
| Structure-Activity Relationship | 7 | 2011 | 3060 | 0.200 |
Why?
|
| Uterine Hemorrhage | 1 | 2003 | 240 | 0.190 |
Why?
|
| Antigens, Bacterial | 1 | 2007 | 1150 | 0.190 |
Why?
|
| NIH 3T3 Cells | 2 | 2019 | 669 | 0.190 |
Why?
|
| Transcription Factors, TFII | 1 | 2001 | 62 | 0.190 |
Why?
|
| Bacterial Proteins | 4 | 2007 | 3835 | 0.190 |
Why?
|
| Epistasis, Genetic | 1 | 2004 | 351 | 0.190 |
Why?
|
| Guanidine | 1 | 2001 | 35 | 0.190 |
Why?
|
| Germ Layers | 1 | 2021 | 73 | 0.190 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2007 | 3794 | 0.190 |
Why?
|
| Proteins | 5 | 2010 | 6006 | 0.180 |
Why?
|
| Mitosis | 3 | 2013 | 1190 | 0.180 |
Why?
|
| Cloning, Molecular | 10 | 2019 | 4168 | 0.180 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2021 | 221 | 0.180 |
Why?
|
| Genes | 8 | 2013 | 1824 | 0.180 |
Why?
|
| Glycerol | 4 | 2003 | 274 | 0.180 |
Why?
|
| Phase Transition | 1 | 2020 | 70 | 0.180 |
Why?
|
| Repetitive Sequences, Amino Acid | 2 | 2012 | 91 | 0.170 |
Why?
|
| Escherichia coli | 7 | 2019 | 4209 | 0.170 |
Why?
|
| Methyltransferases | 2 | 2019 | 373 | 0.170 |
Why?
|
| Amino Acid Motifs | 3 | 2016 | 928 | 0.170 |
Why?
|
| Microscopy, Electron | 3 | 2021 | 2559 | 0.170 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2021 | 285 | 0.170 |
Why?
|
| RNA Interference | 3 | 2013 | 2836 | 0.170 |
Why?
|
| Oncogene Proteins, Viral | 4 | 1990 | 342 | 0.170 |
Why?
|
| Genetic Markers | 3 | 2003 | 2604 | 0.170 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 2019 | 2750 | 0.170 |
Why?
|
| Xenopus | 7 | 2009 | 710 | 0.170 |
Why?
|
| Endoderm | 1 | 2020 | 165 | 0.170 |
Why?
|
| Isotope Labeling | 1 | 2001 | 395 | 0.170 |
Why?
|
| Placenta Accreta | 1 | 2003 | 241 | 0.170 |
Why?
|
| T-Lymphocytes | 12 | 2007 | 10266 | 0.170 |
Why?
|
| DNA, Fungal | 2 | 1998 | 275 | 0.160 |
Why?
|
| Human Growth Hormone | 2 | 2001 | 648 | 0.160 |
Why?
|
| Indazoles | 1 | 2021 | 305 | 0.160 |
Why?
|
| Mass Spectrometry | 3 | 2021 | 2201 | 0.160 |
Why?
|
| Histone Demethylases | 1 | 2021 | 322 | 0.160 |
Why?
|
| Transcriptional Elongation Factors | 2 | 2019 | 167 | 0.160 |
Why?
|
| Truth Disclosure | 1 | 2003 | 433 | 0.160 |
Why?
|
| Histone Chaperones | 1 | 2019 | 85 | 0.160 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2003 | 518 | 0.160 |
Why?
|
| Brachytherapy | 3 | 1997 | 1226 | 0.160 |
Why?
|
| Retroviridae | 1 | 2001 | 849 | 0.150 |
Why?
|
| Mesoderm | 1 | 2021 | 679 | 0.150 |
Why?
|
| Evolution, Molecular | 4 | 2011 | 1893 | 0.150 |
Why?
|
| Peptide Chain Elongation, Translational | 1 | 1998 | 31 | 0.150 |
Why?
|
| DNA-Directed RNA Polymerases | 6 | 2002 | 366 | 0.150 |
Why?
|
| Cadmium | 2 | 1999 | 217 | 0.150 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 6 | 2001 | 1732 | 0.150 |
Why?
|
| Immunoglobulins | 1 | 2001 | 855 | 0.150 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 1998 | 100 | 0.150 |
Why?
|
| Phenotype | 8 | 2021 | 16716 | 0.150 |
Why?
|
| Fibroblasts | 5 | 2016 | 4175 | 0.150 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2021 | 495 | 0.150 |
Why?
|
| Oligodeoxyribonucleotides | 5 | 2001 | 706 | 0.150 |
Why?
|
| Craniofacial Abnormalities | 1 | 2020 | 320 | 0.150 |
Why?
|
| Schizosaccharomyces pombe Proteins | 1 | 1999 | 178 | 0.150 |
Why?
|
| 3T3-L1 Cells | 1 | 2017 | 208 | 0.140 |
Why?
|
| Skeleton | 1 | 2017 | 29 | 0.140 |
Why?
|
| Organelles | 1 | 2019 | 265 | 0.140 |
Why?
|
| Radiotherapy, High-Energy | 1 | 1997 | 228 | 0.140 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2016 | 34 | 0.140 |
Why?
|
| Dimethyl Sulfoxide | 3 | 2003 | 251 | 0.140 |
Why?
|
| Multiprotein Complexes | 5 | 2017 | 1111 | 0.130 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2017 | 102 | 0.130 |
Why?
|
| Lymphocytes | 3 | 2016 | 2610 | 0.130 |
Why?
|
| Intranuclear Space | 1 | 2016 | 15 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2010 | 4526 | 0.130 |
Why?
|
| Dendritic Cells | 1 | 2007 | 2749 | 0.130 |
Why?
|
| DNA, Neoplasm | 3 | 1994 | 1748 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 13 | 2007 | 6228 | 0.130 |
Why?
|
| Cricetinae | 6 | 2003 | 2423 | 0.130 |
Why?
|
| Sequence Analysis | 2 | 2012 | 240 | 0.130 |
Why?
|
| Chemical Phenomena | 2 | 2011 | 486 | 0.130 |
Why?
|
| Pyridones | 1 | 2021 | 818 | 0.130 |
Why?
|
| Cell Culture Techniques | 1 | 2003 | 1666 | 0.130 |
Why?
|
| Growth Disorders | 1 | 2020 | 635 | 0.120 |
Why?
|
| Ovarian Neoplasms | 2 | 2003 | 4908 | 0.120 |
Why?
|
| Immunoprecipitation | 4 | 2013 | 874 | 0.120 |
Why?
|
| Gene Expression | 6 | 2019 | 7595 | 0.120 |
Why?
|
| Precipitin Tests | 4 | 2001 | 816 | 0.120 |
Why?
|
| Phylogeny | 3 | 2011 | 2842 | 0.120 |
Why?
|
| Mice, Mutant Strains | 2 | 2017 | 1755 | 0.120 |
Why?
|
| Pluripotent Stem Cells | 1 | 2021 | 808 | 0.120 |
Why?
|
| Caenorhabditis elegans | 2 | 2014 | 1467 | 0.120 |
Why?
|
| Receptors, Glucocorticoid | 2 | 2007 | 309 | 0.120 |
Why?
|
| Chromatography, Gel | 5 | 2013 | 638 | 0.120 |
Why?
|
| High Mobility Group Proteins | 1 | 1995 | 179 | 0.120 |
Why?
|
| Microscopy | 2 | 2016 | 909 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 5 | 2005 | 6132 | 0.110 |
Why?
|
| Molecular Conformation | 4 | 2001 | 540 | 0.110 |
Why?
|
| 3T3 Cells | 5 | 2000 | 1086 | 0.110 |
Why?
|
| Operon | 4 | 1984 | 371 | 0.110 |
Why?
|
| Substrate Specificity | 5 | 2012 | 1758 | 0.110 |
Why?
|
| Viral Proteins | 6 | 2002 | 1802 | 0.110 |
Why?
|
| Prosencephalon | 1 | 2015 | 306 | 0.110 |
Why?
|
| Gene Deletion | 1 | 2020 | 2673 | 0.110 |
Why?
|
| Cricetulus | 3 | 2003 | 813 | 0.110 |
Why?
|
| Time Factors | 10 | 2016 | 40267 | 0.100 |
Why?
|
| HEPES | 2 | 2003 | 10 | 0.100 |
Why?
|
| Yeasts | 4 | 2001 | 279 | 0.100 |
Why?
|
| DNA Repair | 3 | 2013 | 2050 | 0.100 |
Why?
|
| CHARGE Syndrome | 1 | 2012 | 34 | 0.100 |
Why?
|
| Protein Sorting Signals | 1 | 1993 | 273 | 0.100 |
Why?
|
| Buffers | 2 | 2003 | 143 | 0.100 |
Why?
|
| Chemical Precipitation | 2 | 2003 | 175 | 0.100 |
Why?
|
| Coenzymes | 1 | 2012 | 101 | 0.100 |
Why?
|
| DNA, Complementary | 2 | 1998 | 1992 | 0.100 |
Why?
|
| HEK293 Cells | 1 | 2021 | 4286 | 0.100 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 2012 | 109 | 0.100 |
Why?
|
| Sequence Analysis, RNA | 5 | 2020 | 2038 | 0.100 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2012 | 164 | 0.100 |
Why?
|
| Ubiquitination | 1 | 2017 | 1011 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2021 | 2911 | 0.100 |
Why?
|
| Ribonuclease H | 1 | 2011 | 52 | 0.100 |
Why?
|
| Sequence Alignment | 4 | 2019 | 2177 | 0.100 |
Why?
|
| Herpesvirus 8, Human | 1 | 2013 | 256 | 0.100 |
Why?
|
| Virus Activation | 1 | 2013 | 322 | 0.100 |
Why?
|
| DNA Replication | 3 | 2014 | 1429 | 0.100 |
Why?
|
| Neoplastic Stem Cells | 1 | 2019 | 1356 | 0.100 |
Why?
|
| Leucine Zippers | 3 | 1998 | 116 | 0.100 |
Why?
|
| Carcinoma | 1 | 2003 | 2340 | 0.090 |
Why?
|
| Antigens, Polyomavirus Transforming | 2 | 1989 | 256 | 0.090 |
Why?
|
| Immune Tolerance | 4 | 2010 | 2324 | 0.090 |
Why?
|
| X Chromosome Inactivation | 1 | 2013 | 229 | 0.090 |
Why?
|
| Hydrogen Bonding | 1 | 2011 | 290 | 0.090 |
Why?
|
| Actins | 1 | 1999 | 2059 | 0.090 |
Why?
|
| Species Specificity | 5 | 2014 | 2417 | 0.090 |
Why?
|
| Peptides | 2 | 2021 | 4352 | 0.090 |
Why?
|
| Static Electricity | 1 | 2011 | 261 | 0.090 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 2 | 2001 | 166 | 0.090 |
Why?
|
| Retinoblastoma-Binding Protein 4 | 2 | 2008 | 12 | 0.090 |
Why?
|
| Radioimmunoassay | 2 | 2001 | 862 | 0.090 |
Why?
|
| Transcription Factor TFIID | 3 | 2001 | 150 | 0.090 |
Why?
|
| Consensus Sequence | 3 | 2002 | 363 | 0.090 |
Why?
|
| Phosphorylation | 6 | 2020 | 8326 | 0.090 |
Why?
|
| Receptors, Antigen, T-Cell | 9 | 1990 | 2568 | 0.090 |
Why?
|
| Sirtuins | 1 | 2013 | 322 | 0.090 |
Why?
|
| Solutions | 2 | 2001 | 409 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 6 | 2009 | 6084 | 0.090 |
Why?
|
| Alleles | 1 | 2021 | 6892 | 0.090 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 1997 | 2044 | 0.090 |
Why?
|
| Serine Endopeptidases | 2 | 2002 | 1026 | 0.090 |
Why?
|
| Blotting, Western | 4 | 2004 | 5033 | 0.090 |
Why?
|
| Genome, Fungal | 2 | 2009 | 203 | 0.080 |
Why?
|
| DNA-Cytosine Methylases | 1 | 2009 | 17 | 0.080 |
Why?
|
| Stem Cells | 2 | 2021 | 3537 | 0.080 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2012 | 393 | 0.080 |
Why?
|
| Dimerization | 3 | 2001 | 886 | 0.080 |
Why?
|
| Physician-Patient Relations | 1 | 2003 | 3267 | 0.080 |
Why?
|
| Genes, Insect | 2 | 2001 | 265 | 0.080 |
Why?
|
| Surgical Procedures, Operative | 1 | 2001 | 1937 | 0.080 |
Why?
|
| Protein Structure, Secondary | 2 | 2008 | 1216 | 0.080 |
Why?
|
| Genes, Viral | 3 | 1992 | 655 | 0.080 |
Why?
|
| Muscle Proteins | 2 | 1992 | 1165 | 0.080 |
Why?
|
| Antigens, Viral, Tumor | 2 | 1986 | 153 | 0.080 |
Why?
|
| Oncogenes | 2 | 1985 | 1234 | 0.080 |
Why?
|
| Genomic Instability | 1 | 2013 | 715 | 0.080 |
Why?
|
| Thermodynamics | 2 | 2001 | 590 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2010 | 2889 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 1999 | 1684 | 0.080 |
Why?
|
| Referral and Consultation | 1 | 2002 | 3627 | 0.080 |
Why?
|
| Ovum | 1 | 2009 | 187 | 0.080 |
Why?
|
| Genital Neoplasms, Female | 1 | 1994 | 538 | 0.080 |
Why?
|
| RNA, Small Interfering | 3 | 2020 | 3436 | 0.080 |
Why?
|
| Gene Regulatory Networks | 3 | 2021 | 1753 | 0.080 |
Why?
|
| Proto-Oncogenes | 2 | 1994 | 322 | 0.070 |
Why?
|
| Simian virus 40 | 4 | 1992 | 292 | 0.070 |
Why?
|
| Recreation | 1 | 2008 | 124 | 0.070 |
Why?
|
| Surface Plasmon Resonance | 1 | 2008 | 272 | 0.070 |
Why?
|
| Protein Folding | 1 | 2011 | 872 | 0.070 |
Why?
|
| K562 Cells | 4 | 2016 | 637 | 0.070 |
Why?
|
| Mutagenesis | 1 | 2011 | 1229 | 0.070 |
Why?
|
| Dietary Supplements | 1 | 2000 | 3443 | 0.070 |
Why?
|
| Accidents | 1 | 2008 | 164 | 0.070 |
Why?
|
| Globins | 2 | 2005 | 405 | 0.070 |
Why?
|
| Zinc Fingers | 3 | 2005 | 577 | 0.070 |
Why?
|
| Genome, Human | 4 | 2020 | 4450 | 0.070 |
Why?
|
| Xenopus laevis | 3 | 2004 | 966 | 0.070 |
Why?
|
| DNA Damage | 2 | 2014 | 2459 | 0.070 |
Why?
|
| Protein Multimerization | 1 | 2011 | 972 | 0.070 |
Why?
|
| Algorithms | 1 | 2007 | 14154 | 0.070 |
Why?
|
| Rad51 Recombinase | 1 | 2007 | 191 | 0.070 |
Why?
|
| RecQ Helicases | 1 | 2006 | 53 | 0.070 |
Why?
|
| Amino Acids | 1 | 2012 | 1716 | 0.070 |
Why?
|
| Hypogonadism | 1 | 2012 | 805 | 0.070 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2013 | 878 | 0.070 |
Why?
|
| TATA-Box Binding Protein | 3 | 1996 | 99 | 0.070 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1998 | 492 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 1998 | 474 | 0.070 |
Why?
|
| Baculoviridae | 2 | 2019 | 115 | 0.070 |
Why?
|
| Protein Kinases | 2 | 1999 | 1609 | 0.070 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group C | 1 | 2005 | 17 | 0.060 |
Why?
|
| Adenoviridae | 3 | 1985 | 1093 | 0.060 |
Why?
|
| Locus Control Region | 1 | 2005 | 21 | 0.060 |
Why?
|
| Xenopus Proteins | 2 | 2009 | 435 | 0.060 |
Why?
|
| Embryo, Nonmammalian | 3 | 2014 | 911 | 0.060 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 2 | 2002 | 133 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2006 | 10776 | 0.060 |
Why?
|
| Cytoplasm | 4 | 2001 | 1500 | 0.060 |
Why?
|
| Peptide Mapping | 2 | 1996 | 259 | 0.060 |
Why?
|
| DNA Primers | 5 | 2015 | 2823 | 0.060 |
Why?
|
| Chromosomes, Mammalian | 1 | 2006 | 148 | 0.060 |
Why?
|
| Cell-Free System | 3 | 1999 | 340 | 0.060 |
Why?
|
| Longevity | 1 | 2013 | 1077 | 0.060 |
Why?
|
| DNA, Single-Stranded | 1 | 2007 | 352 | 0.060 |
Why?
|
| Protein Subunits | 3 | 2007 | 943 | 0.060 |
Why?
|
| Serine | 2 | 2020 | 831 | 0.060 |
Why?
|
| Guanosine Tetraphosphate | 2 | 1981 | 11 | 0.060 |
Why?
|
| Genes, Fungal | 2 | 1999 | 439 | 0.060 |
Why?
|
| Organ Specificity | 4 | 2016 | 1966 | 0.060 |
Why?
|
| Helix-Loop-Helix Motifs | 2 | 1995 | 97 | 0.060 |
Why?
|
| BALB 3T3 Cells | 1 | 2003 | 10 | 0.060 |
Why?
|
| DNA, Superhelical | 3 | 2000 | 51 | 0.060 |
Why?
|
| Mice, Knockout | 5 | 2016 | 14481 | 0.060 |
Why?
|
| Spleen | 3 | 2007 | 2295 | 0.060 |
Why?
|
| DNA, Circular | 1 | 2003 | 97 | 0.050 |
Why?
|
| Immunomagnetic Separation | 1 | 2003 | 79 | 0.050 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 2 | 2001 | 116 | 0.050 |
Why?
|
| Epitopes | 2 | 2001 | 2525 | 0.050 |
Why?
|
| DNA Restriction Enzymes | 2 | 2001 | 548 | 0.050 |
Why?
|
| Histone Acetyltransferases | 2 | 2002 | 335 | 0.050 |
Why?
|
| Gene Knockout Techniques | 2 | 2016 | 808 | 0.050 |
Why?
|
| Huntington Disease | 1 | 2009 | 1147 | 0.050 |
Why?
|
| Glutamate-Ammonia Ligase | 1 | 2002 | 76 | 0.050 |
Why?
|
| Mice, Inbred CBA | 10 | 1990 | 438 | 0.050 |
Why?
|
| Computational Biology | 2 | 2020 | 3541 | 0.050 |
Why?
|
| DNA Mutational Analysis | 5 | 1993 | 4120 | 0.050 |
Why?
|
| Polymerization | 1 | 2023 | 156 | 0.050 |
Why?
|
| Nuclease Protection Assays | 1 | 2001 | 14 | 0.050 |
Why?
|
| RNA, Ribosomal, 5S | 1 | 2001 | 10 | 0.050 |
Why?
|
| Rats | 4 | 2006 | 23833 | 0.050 |
Why?
|
| Protein Methyltransferases | 2 | 2017 | 54 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 5 | 2019 | 22355 | 0.050 |
Why?
|
| Peptide Elongation Factors | 1 | 1981 | 60 | 0.050 |
Why?
|
| Antigens, Surface | 3 | 1986 | 1616 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 1991 | 2448 | 0.050 |
Why?
|
| Heat-Shock Response | 2 | 2004 | 179 | 0.050 |
Why?
|
| Trypsin | 2 | 2000 | 491 | 0.050 |
Why?
|
| Organ Culture Techniques | 9 | 2001 | 796 | 0.050 |
Why?
|
| Peptide Fragments | 2 | 2008 | 5151 | 0.050 |
Why?
|
| Ureteral Obstruction | 1 | 2003 | 297 | 0.050 |
Why?
|
| Temperature | 3 | 1996 | 2234 | 0.050 |
Why?
|
| Sin3 Histone Deacetylase and Corepressor Complex | 1 | 2001 | 19 | 0.050 |
Why?
|
| Protoplasts | 1 | 2001 | 45 | 0.050 |
Why?
|
| Chromatography, Thin Layer | 1 | 2001 | 213 | 0.050 |
Why?
|
| Calcium Chloride | 1 | 2001 | 79 | 0.050 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 1992 | 282 | 0.050 |
Why?
|
| Base Pair Mismatch | 1 | 2001 | 93 | 0.050 |
Why?
|
| Guanine Nucleotides | 1 | 1981 | 55 | 0.050 |
Why?
|
| Densitometry | 1 | 2001 | 151 | 0.050 |
Why?
|
| Microscopy, Atomic Force | 1 | 2001 | 251 | 0.050 |
Why?
|
| Magnesium Chloride | 1 | 2000 | 30 | 0.050 |
Why?
|
| Culture Media | 1 | 2003 | 898 | 0.050 |
Why?
|
| Osmotic Pressure | 1 | 2001 | 137 | 0.050 |
Why?
|
| Alkanesulfonic Acids | 1 | 2003 | 203 | 0.050 |
Why?
|
| Recombination, Genetic | 3 | 2002 | 1526 | 0.040 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2003 | 737 | 0.040 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 1 | 2000 | 111 | 0.040 |
Why?
|
| Female | 26 | 2020 | 397050 | 0.040 |
Why?
|
| Drug Stability | 1 | 2001 | 291 | 0.040 |
Why?
|
| Virus Integration | 1 | 2002 | 306 | 0.040 |
Why?
|
| Ribonucleases | 1 | 2001 | 265 | 0.040 |
Why?
|
| Male | 13 | 2023 | 364870 | 0.040 |
Why?
|
| Autoradiography | 1 | 2001 | 732 | 0.040 |
Why?
|
| Potassium Chloride | 1 | 2000 | 229 | 0.040 |
Why?
|
| Dinoprostone | 1 | 2023 | 597 | 0.040 |
Why?
|
| Quality Control | 1 | 2003 | 833 | 0.040 |
Why?
|
| RNA Helicases | 1 | 2001 | 144 | 0.040 |
Why?
|
| Catalysis | 1 | 2001 | 769 | 0.040 |
Why?
|
| Meiosis | 2 | 2014 | 327 | 0.040 |
Why?
|
| Carbon Radioisotopes | 1 | 2001 | 567 | 0.040 |
Why?
|
| Microspheres | 1 | 2003 | 789 | 0.040 |
Why?
|
| Professional Competence | 1 | 2003 | 430 | 0.040 |
Why?
|
| Deoxyguanosine | 3 | 1985 | 96 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2016 | 2524 | 0.040 |
Why?
|
| Centrifugation | 2 | 2001 | 122 | 0.040 |
Why?
|
| Sequence Deletion | 2 | 2007 | 1496 | 0.040 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2005 | 736 | 0.040 |
Why?
|
| Liposomes | 1 | 2003 | 792 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1991 | 1056 | 0.040 |
Why?
|
| Spodoptera | 1 | 2019 | 141 | 0.040 |
Why?
|
| Genetic Variation | 2 | 2012 | 6606 | 0.040 |
Why?
|
| Molecular Weight | 2 | 1995 | 2172 | 0.040 |
Why?
|
| Lymphocyte Activation | 4 | 2007 | 5496 | 0.040 |
Why?
|
| Exanthema | 1 | 2003 | 503 | 0.040 |
Why?
|
| Mediator Complex | 1 | 1999 | 106 | 0.040 |
Why?
|
| Hospitals, Pediatric | 1 | 2008 | 1876 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2007 | 10464 | 0.040 |
Why?
|
| DNA Probes | 3 | 1994 | 542 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2001 | 1647 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2019 | 9197 | 0.040 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 3 | 1990 | 896 | 0.040 |
Why?
|
| Specialization | 1 | 2003 | 781 | 0.040 |
Why?
|
| Crosses, Genetic | 1 | 1999 | 753 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2016 | 2474 | 0.040 |
Why?
|
| Carbon | 1 | 2001 | 672 | 0.040 |
Why?
|
| Cell Transformation, Viral | 3 | 1990 | 530 | 0.040 |
Why?
|
| Pharmacists | 1 | 2000 | 261 | 0.040 |
Why?
|
| History, Medieval | 1 | 2017 | 62 | 0.040 |
Why?
|
| Athletic Injuries | 1 | 2008 | 1245 | 0.040 |
Why?
|
| Renal Insufficiency | 1 | 2003 | 809 | 0.040 |
Why?
|
| Oxidative Stress | 2 | 2013 | 3139 | 0.040 |
Why?
|
| RNA, Fungal | 1 | 1998 | 156 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2016 | 4584 | 0.040 |
Why?
|
| Medical Records | 1 | 2003 | 1413 | 0.040 |
Why?
|
| United States | 3 | 2021 | 73144 | 0.040 |
Why?
|
| Genes, X-Linked | 1 | 2017 | 128 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2001 | 861 | 0.030 |
Why?
|
| Creatine Kinase | 2 | 1990 | 685 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2009 | 4414 | 0.030 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2001 | 388 | 0.030 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1998 | 329 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 1999 | 662 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 1998 | 1553 | 0.030 |
Why?
|
| Mitogens | 1 | 1996 | 229 | 0.030 |
Why?
|
| RNA, Ribosomal | 3 | 2001 | 227 | 0.030 |
Why?
|
| Microcephaly | 1 | 2020 | 426 | 0.030 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2016 | 98 | 0.030 |
Why?
|
| RNA-Binding Protein FUS | 1 | 2016 | 77 | 0.030 |
Why?
|
| Introns | 2 | 2012 | 968 | 0.030 |
Why?
|
| Protein Biosynthesis | 4 | 2009 | 2094 | 0.030 |
Why?
|
| Adenovirus Early Proteins | 3 | 1990 | 58 | 0.030 |
Why?
|
| Methotrexate | 1 | 2002 | 1722 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2013 | 504 | 0.030 |
Why?
|
| Epithelial Cells | 4 | 2020 | 3692 | 0.030 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 1996 | 67 | 0.030 |
Why?
|
| Survival Rate | 2 | 2002 | 12870 | 0.030 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2020 | 605 | 0.030 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2016 | 420 | 0.030 |
Why?
|
| Enzyme Activation | 2 | 2002 | 3585 | 0.030 |
Why?
|
| Embryo, Mammalian | 3 | 2014 | 1674 | 0.030 |
Why?
|
| Chemistry, Physical | 1 | 1995 | 153 | 0.030 |
Why?
|
| Multienzyme Complexes | 1 | 1998 | 666 | 0.030 |
Why?
|
| Micrognathism | 1 | 2015 | 64 | 0.030 |
Why?
|
| Heat Stress Disorders | 1 | 1996 | 80 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2006 | 8198 | 0.030 |
Why?
|
| Polyomavirus | 2 | 1986 | 235 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 2016 | 808 | 0.030 |
Why?
|
| Proline | 1 | 1996 | 455 | 0.030 |
Why?
|
| Protein Denaturation | 1 | 1995 | 242 | 0.030 |
Why?
|
| Oocytes | 2 | 2009 | 1171 | 0.030 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 1995 | 148 | 0.030 |
Why?
|
| Protein Structure, Quaternary | 1 | 2016 | 427 | 0.030 |
Why?
|
| Chromatography, Affinity | 2 | 1994 | 525 | 0.030 |
Why?
|
| Prophase | 1 | 2014 | 16 | 0.030 |
Why?
|
| Nuclear Lamina | 1 | 2014 | 46 | 0.030 |
Why?
|
| Medicine | 1 | 2003 | 948 | 0.030 |
Why?
|
| Transcription Factor TFIIA | 1 | 1994 | 17 | 0.030 |
Why?
|
| Transcription Factor TFIIB | 1 | 1994 | 25 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 1999 | 1563 | 0.030 |
Why?
|
| Autoantigens | 3 | 2008 | 891 | 0.030 |
Why?
|
| Chromosome Pairing | 1 | 2014 | 46 | 0.030 |
Why?
|
| Software | 1 | 2008 | 4452 | 0.030 |
Why?
|
| Hand Deformities, Congenital | 1 | 2015 | 175 | 0.030 |
Why?
|
| Prokaryotic Cells | 1 | 1994 | 53 | 0.030 |
Why?
|
| Cell Line, Tumor | 3 | 2020 | 17132 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1994 | 417 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2001 | 1496 | 0.030 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 1994 | 153 | 0.030 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2016 | 648 | 0.030 |
Why?
|
| Transgenes | 1 | 2017 | 1015 | 0.030 |
Why?
|
| Estrogens | 1 | 2000 | 1534 | 0.030 |
Why?
|
| Centromere | 1 | 2014 | 215 | 0.030 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2014 | 115 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2017 | 612 | 0.030 |
Why?
|
| Heterozygote | 1 | 2020 | 2792 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1997 | 1355 | 0.030 |
Why?
|
| Cytokines | 2 | 2007 | 7443 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1985 | 3407 | 0.030 |
Why?
|
| Phleomycins | 1 | 1992 | 1 | 0.030 |
Why?
|
| Genes, Regulator | 2 | 2003 | 373 | 0.030 |
Why?
|
| Mutation, Missense | 2 | 2017 | 2593 | 0.030 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2016 | 428 | 0.030 |
Why?
|
| Restriction Mapping | 2 | 1990 | 849 | 0.030 |
Why?
|
| Receptors, AMPA | 1 | 2014 | 335 | 0.030 |
Why?
|
| Enzyme Stability | 1 | 2012 | 219 | 0.030 |
Why?
|
| Transcription Factor 7-Like 1 Protein | 1 | 1992 | 24 | 0.030 |
Why?
|
| Myogenin | 1 | 1992 | 54 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2000 | 2247 | 0.020 |
Why?
|
| Neuropeptides | 1 | 1998 | 950 | 0.020 |
Why?
|
| Neoplasms | 2 | 2014 | 22389 | 0.020 |
Why?
|
| Molecular Sequence Annotation | 1 | 2014 | 525 | 0.020 |
Why?
|
| Th1 Cells | 1 | 1997 | 1042 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 1997 | 1209 | 0.020 |
Why?
|
| TCF Transcription Factors | 1 | 1992 | 138 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2001 | 3663 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 3 | 1984 | 1438 | 0.020 |
Why?
|
| Interleukin-2 | 2 | 1989 | 1894 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1993 | 781 | 0.020 |
Why?
|
| Infant | 3 | 2020 | 36512 | 0.020 |
Why?
|
| Hippocampus | 2 | 2014 | 3784 | 0.020 |
Why?
|
| Oxidoreductases, O-Demethylating | 1 | 2010 | 4 | 0.020 |
Why?
|
| Middle Aged | 7 | 2020 | 223463 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 1999 | 1885 | 0.020 |
Why?
|
| Epigenomics | 1 | 2016 | 959 | 0.020 |
Why?
|
| Neck | 1 | 2015 | 736 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2020 | 42654 | 0.020 |
Why?
|
| Upstream Stimulatory Factors | 1 | 1990 | 18 | 0.020 |
Why?
|
| Radiation Injuries | 1 | 1997 | 1204 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2010 | 20224 | 0.020 |
Why?
|
| Medical Oncology | 1 | 2002 | 2348 | 0.020 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 1990 | 175 | 0.020 |
Why?
|
| Prognosis | 2 | 2003 | 30020 | 0.020 |
Why?
|
| Cell Survival | 3 | 1989 | 5792 | 0.020 |
Why?
|
| RNA, Bacterial | 2 | 1981 | 394 | 0.020 |
Why?
|
| Heart | 1 | 2002 | 4449 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 1994 | 1141 | 0.020 |
Why?
|
| MyoD Protein | 1 | 1989 | 141 | 0.020 |
Why?
|
| Drug Resistance, Microbial | 1 | 1992 | 830 | 0.020 |
Why?
|
| Face | 1 | 2015 | 1031 | 0.020 |
Why?
|
| Mice, Nude | 4 | 1997 | 3630 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2001 | 3707 | 0.020 |
Why?
|
| Enterotoxins | 1 | 1990 | 365 | 0.020 |
Why?
|
| Oogenesis | 1 | 2009 | 125 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2003 | 81768 | 0.020 |
Why?
|
| Base Composition | 1 | 2009 | 291 | 0.020 |
Why?
|
| Polymers | 1 | 2016 | 1630 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2008 | 16027 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 1992 | 762 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 1989 | 288 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2002 | 12092 | 0.020 |
Why?
|
| Signal Transduction | 4 | 2020 | 23629 | 0.020 |
Why?
|
| Adenoviruses, Human | 1 | 1990 | 257 | 0.020 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2007 | 41 | 0.020 |
Why?
|
| Ireland | 1 | 2008 | 170 | 0.020 |
Why?
|
| Single-Strand Specific DNA and RNA Endonucleases | 1 | 1987 | 31 | 0.020 |
Why?
|
| Aged | 4 | 2003 | 171544 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 2015 | 1424 | 0.020 |
Why?
|
| Cross-Linking Reagents | 2 | 2002 | 692 | 0.020 |
Why?
|
| H-2 Antigens | 2 | 1985 | 359 | 0.020 |
Why?
|
| RNA Splicing | 1 | 2012 | 903 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 1990 | 749 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2016 | 2630 | 0.020 |
Why?
|
| Adult | 6 | 2020 | 223622 | 0.020 |
Why?
|
| Pregnancy | 5 | 2003 | 30198 | 0.020 |
Why?
|
| Radiotherapy Dosage | 1 | 1994 | 2920 | 0.020 |
Why?
|
| Cell Division | 2 | 2002 | 4478 | 0.020 |
Why?
|
| Cadmium Compounds | 1 | 1986 | 15 | 0.020 |
Why?
|
| DNA, Bacterial | 2 | 1981 | 1479 | 0.020 |
Why?
|
| Exons | 1 | 2012 | 2392 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2013 | 1315 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2001 | 14736 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 1622 | 0.020 |
Why?
|
| Biological Evolution | 1 | 1991 | 1079 | 0.020 |
Why?
|
| Deltaretrovirus | 1 | 1985 | 162 | 0.020 |
Why?
|
| Herpesvirus 1, Suid | 1 | 1985 | 25 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2002 | 4748 | 0.020 |
Why?
|
| Child | 3 | 2020 | 80894 | 0.020 |
Why?
|
| Adolescent | 3 | 2020 | 89182 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2012 | 2937 | 0.020 |
Why?
|
| Sulfates | 1 | 1986 | 379 | 0.010 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2008 | 794 | 0.010 |
Why?
|
| Gene Components | 1 | 2004 | 27 | 0.010 |
Why?
|
| Endonucleases | 1 | 1987 | 371 | 0.010 |
Why?
|
| Necrosis | 1 | 1989 | 1619 | 0.010 |
Why?
|
| Antigens, Ly | 1 | 1985 | 296 | 0.010 |
Why?
|
| Hemin | 1 | 2004 | 51 | 0.010 |
Why?
|
| Research Support as Topic | 1 | 2008 | 696 | 0.010 |
Why?
|
| Growth Hormone | 1 | 1986 | 573 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2001 | 59683 | 0.010 |
Why?
|
| Interleukins | 1 | 1989 | 795 | 0.010 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2004 | 67 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 3666 | 0.010 |
Why?
|
| Carrier Proteins | 3 | 2002 | 4940 | 0.010 |
Why?
|
| Hemoglobins, Abnormal | 2 | 1981 | 119 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2004 | 461 | 0.010 |
Why?
|
| Germ Cells | 1 | 2007 | 643 | 0.010 |
Why?
|
| ATP-Dependent Proteases | 1 | 2002 | 23 | 0.010 |
Why?
|
| T-Phages | 1 | 1983 | 90 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2002 | 65365 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2004 | 946 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 1997 | 11254 | 0.010 |
Why?
|
| Hemoglobin A | 2 | 1980 | 84 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 6541 | 0.010 |
Why?
|
| Staphylococcus aureus | 1 | 1990 | 1428 | 0.010 |
Why?
|
| Pattern Recognition, Automated | 1 | 2008 | 998 | 0.010 |
Why?
|
| Transplantation Immunology | 1 | 1984 | 538 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1984 | 1769 | 0.010 |
Why?
|
| Clone Cells | 1 | 1985 | 1671 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 1997 | 4981 | 0.010 |
Why?
|
| Microsomes | 1 | 2001 | 252 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 11117 | 0.010 |
Why?
|
| Simplexvirus | 1 | 1985 | 805 | 0.010 |
Why?
|
| Thiocyanates | 1 | 2001 | 70 | 0.010 |
Why?
|
| Phenol | 1 | 2001 | 44 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2001 | 298 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 1987 | 1416 | 0.010 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2004 | 423 | 0.010 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 2000 | 42 | 0.010 |
Why?
|
| Cockayne Syndrome | 1 | 2000 | 20 | 0.010 |
Why?
|
| Erythroid-Specific DNA-Binding Factors | 1 | 2000 | 195 | 0.010 |
Why?
|
| Detergents | 1 | 2001 | 235 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2004 | 8628 | 0.010 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2001 | 200 | 0.010 |
Why?
|
| Antibodies | 1 | 1989 | 2425 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 1989 | 3164 | 0.010 |
Why?
|
| Genetic Engineering | 1 | 1986 | 936 | 0.010 |
Why?
|
| Autoimmunity | 1 | 2008 | 1360 | 0.010 |
Why?
|
| Torsion Abnormality | 1 | 2000 | 92 | 0.010 |
Why?
|
| Guanidines | 1 | 2001 | 194 | 0.010 |
Why?
|
| CREB-Binding Protein | 1 | 2000 | 147 | 0.010 |
Why?
|
| Cell Extracts | 1 | 2000 | 135 | 0.010 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2000 | 293 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1996 | 4069 | 0.010 |
Why?
|
| Ovary | 1 | 1984 | 960 | 0.010 |
Why?
|
| Outpatients | 1 | 2008 | 1603 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2013 | 6277 | 0.010 |
Why?
|
| Cardiomegaly | 1 | 2002 | 591 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2008 | 4137 | 0.010 |
Why?
|
| Enzymes | 1 | 2001 | 254 | 0.010 |
Why?
|
| Azides | 1 | 1999 | 120 | 0.010 |
Why?
|
| Photoaffinity Labels | 1 | 1999 | 85 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 1997 | 39405 | 0.010 |
Why?
|
| Gestational Age | 4 | 1990 | 3615 | 0.010 |
Why?
|
| DNA Repair Enzymes | 1 | 2000 | 346 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 1999 | 247 | 0.010 |
Why?
|
| Lymnaea | 1 | 1998 | 8 | 0.010 |
Why?
|
| Hemoglobin, Sickle | 1 | 1978 | 113 | 0.010 |
Why?
|
| Invertebrate Hormones | 1 | 1998 | 24 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2003 | 1704 | 0.010 |
Why?
|
| Fetal Hemoglobin | 1 | 1981 | 346 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1996 | 6404 | 0.010 |
Why?
|
| Sickle Cell Trait | 1 | 1978 | 86 | 0.010 |
Why?
|
| Thalassemia | 1 | 1978 | 267 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2000 | 325 | 0.010 |
Why?
|
| G1 Phase | 1 | 1999 | 402 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 9563 | 0.010 |
Why?
|
| Hydroxamic Acids | 1 | 2000 | 482 | 0.010 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2000 | 507 | 0.010 |
Why?
|
| beta Catenin | 1 | 2002 | 1047 | 0.010 |
Why?
|
| Ikaros Transcription Factor | 1 | 1999 | 233 | 0.010 |
Why?
|
| Myocardium | 2 | 2002 | 4788 | 0.010 |
Why?
|
| Liver | 2 | 1990 | 7570 | 0.010 |
Why?
|
| Chickens | 1 | 1999 | 845 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 1998 | 738 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2013 | 5830 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2002 | 1337 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2004 | 1748 | 0.010 |
Why?
|
| Hematologic Diseases | 1 | 1981 | 499 | 0.010 |
Why?
|
| Immunoglobulin Isotypes | 1 | 1997 | 158 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 2 | 1989 | 564 | 0.010 |
Why?
|
| Antibodies, Fungal | 1 | 1996 | 33 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1997 | 574 | 0.010 |
Why?
|
| Epithelium | 3 | 1985 | 1609 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1985 | 2846 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1996 | 11854 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1993 | 9433 | 0.010 |
Why?
|
| Bleomycin | 1 | 1996 | 493 | 0.010 |
Why?
|
| Escherichia coli Proteins | 1 | 1981 | 1057 | 0.010 |
Why?
|
| Fetal Blood | 1 | 1981 | 1361 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1998 | 1905 | 0.010 |
Why?
|
| Chromosome Deletion | 2 | 1990 | 1390 | 0.010 |
Why?
|
| Protein Precursors | 1 | 1998 | 1134 | 0.010 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 1997 | 552 | 0.010 |
Why?
|
| Ligands | 1 | 2000 | 3283 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 60048 | 0.010 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 1994 | 167 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 1998 | 1527 | 0.010 |
Why?
|
| Chimera | 2 | 1985 | 454 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2000 | 2487 | 0.010 |
Why?
|
| Bacteria | 1 | 1983 | 2222 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1981 | 2421 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2007 | 3794 | 0.010 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 1990 | 111 | 0.010 |
Why?
|
| Anemia, Sickle Cell | 1 | 1978 | 1065 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 18358 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 1996 | 2226 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1990 | 777 | 0.010 |
Why?
|
| Cisplatin | 1 | 1996 | 1661 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 1990 | 455 | 0.010 |
Why?
|
| Digestive System | 1 | 1990 | 244 | 0.010 |
Why?
|
| Treatment Failure | 1 | 1996 | 2664 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 3 | 1996 | 9261 | 0.000 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1988 | 205 | 0.000 |
Why?
|
| Antigen-Antibody Complex | 1 | 1989 | 513 | 0.000 |
Why?
|
| Concanavalin A | 1 | 1986 | 190 | 0.000 |
Why?
|
| Genotype | 1 | 2001 | 13038 | 0.000 |
Why?
|
| Isoenzymes | 1 | 1990 | 1684 | 0.000 |
Why?
|
| Interleukin-4 | 1 | 1989 | 1157 | 0.000 |
Why?
|
| DNA, Viral | 1 | 1992 | 2205 | 0.000 |
Why?
|
| Animals, Newborn | 1 | 1990 | 2695 | 0.000 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 1985 | 510 | 0.000 |
Why?
|
| Vincristine | 1 | 1986 | 1040 | 0.000 |
Why?
|
| Combined Modality Therapy | 1 | 1996 | 8562 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2008 | 54921 | 0.000 |
Why?
|
| Immunoenzyme Techniques | 1 | 1986 | 1705 | 0.000 |
Why?
|
| Blood | 1 | 1986 | 597 | 0.000 |
Why?
|
| Survival Analysis | 1 | 1996 | 10117 | 0.000 |
Why?
|
| HIV-1 | 1 | 2000 | 6963 | 0.000 |
Why?
|
| Mice, Inbred AKR | 1 | 1982 | 104 | 0.000 |
Why?
|
| Pilot Projects | 1 | 1996 | 8730 | 0.000 |
Why?
|
| Terminology as Topic | 1 | 1989 | 1539 | 0.000 |
Why?
|
| Electrophoresis, Cellulose Acetate | 1 | 1980 | 16 | 0.000 |
Why?
|
| Brain | 1 | 1988 | 27452 | 0.000 |
Why?
|
| Reticulocytes | 1 | 1980 | 288 | 0.000 |
Why?
|
| Language | 1 | 1989 | 1558 | 0.000 |
Why?
|
| Energy Metabolism | 1 | 1990 | 2906 | 0.000 |
Why?
|
| Cell Communication | 1 | 1985 | 1660 | 0.000 |
Why?
|
| Cell Separation | 1 | 1981 | 1725 | 0.000 |
Why?
|
| Graft Survival | 1 | 1984 | 3900 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1981 | 26410 | 0.000 |
Why?
|